New York State Common Retirement Fund’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $682K | Hold |
48,670
| – | – | ﹤0.01% | 1803 |
|
|
2025
Q1 | $761K | Buy |
48,670
+23,503
| +93% | +$367K | ﹤0.01% | 1737 |
|
|
2024
Q4 | $351K | Hold |
25,167
| – | – | ﹤0.01% | 2063 |
|
|
2024
Q3 | $234K | Sell |
25,167
-18,500
| -42% | -$172K | ﹤0.01% | 2215 |
|
|
2024
Q2 | $406K | Buy |
43,667
+11,972
| +38% | +$111K | ﹤0.01% | 2121 |
|
|
2024
Q1 | $314K | Buy |
31,695
+16,773
| +112% | +$166K | ﹤0.01% | 2263 |
|
|
2023
Q4 | $48K | Sell |
14,922
-119
| -0.8% | -$383 | ﹤0.01% | 3004 |
|
|
2023
Q3 | $80K | Buy |
15,041
+239
| +2% | +$1.27K | ﹤0.01% | 2831 |
|
|
2023
Q2 | $141K | Sell |
14,802
-9,164
| -38% | -$87.3K | ﹤0.01% | 2649 |
|
|
2023
Q1 | $264K | Sell |
23,966
-5,985
| -20% | -$65.9K | ﹤0.01% | 2477 |
|
|
2022
Q4 | $443K | Buy |
29,951
+5,367
| +22% | +$79.4K | ﹤0.01% | 2369 |
|
|
2022
Q3 | $470K | Buy |
24,584
+197
| +0.8% | +$3.77K | ﹤0.01% | 2353 |
|
|
2022
Q2 | $520K | Buy |
24,387
+5,434
| +29% | +$116K | ﹤0.01% | 2354 |
|
|
2022
Q1 | $365K | Buy |
18,953
+20
| +0.1% | +$385 | ﹤0.01% | 2543 |
|
|
2021
Q4 | $393K | Sell |
18,933
-62
| -0.3% | -$1.29K | ﹤0.01% | 2559 |
|
|
2021
Q3 | $454K | Sell |
18,995
-4,897
| -20% | -$117K | ﹤0.01% | 2518 |
|
|
2021
Q2 | $652K | Buy |
23,892
+5,692
| +31% | +$155K | ﹤0.01% | 2456 |
|
|
2021
Q1 | $527K | Hold |
18,200
| – | – | ﹤0.01% | 2425 |
|
|
2020
Q4 | $512K | Buy |
18,200
+8,800
| +94% | +$248K | ﹤0.01% | 2344 |
|
|
2020
Q3 | $275K | Hold |
9,400
| – | – | ﹤0.01% | 2510 |
|
|
2020
Q2 | $284K | Buy |
+9,400
| New | +$284K | ﹤0.01% | 2490 |
|